If cannabis investors want to pick the winners, then they need to focus on the companies based in the U.S.
Although Canada’s market is expected to grow twice as fast as the American market from 2020 to 2021, and nearly three times faster from 2021 to 2022, it still can’t match the sales numbers of its southern neighbor.
While some believe this is a bad time to buy — catching a falling knife — the group has been in an overall uptrend since March 2020.
Of course, just logging big sales is no indication that the share price will follow.